Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Cellular stress response to extremely low-frequency electromagnetic fields (ELF-EMF): An explanation for controversial effects of ELF-EMF on apoptosis.
Cell Prolif. 2021 Dec;54(12):e13154. doi: 10.1111/cpr.13154. Epub 2021 Nov 6.
Cell Prolif. 2021.
PMID: 34741480
Free PMC article.
Review.
Matrix stiffening and acquired resistance to chemotherapy: concepts and clinical significance.
Darvishi B, Eisavand MR, Majidzadeh-A K, Farahmand L.
Darvishi B, et al. Among authors: eisavand mr.
Br J Cancer. 2022 May;126(9):1253-1263. doi: 10.1038/s41416-021-01680-8. Epub 2022 Feb 5.
Br J Cancer. 2022.
PMID: 35124704
Free PMC article.
Review.
Item in Clipboard
Crosstalk between MUC1 and VEGF in angiogenesis and metastasis: a review highlighting roles of the MUC1 with an emphasis on metastatic and angiogenic signaling.
Khodabakhsh F, Merikhian P, Eisavand MR, Farahmand L.
Khodabakhsh F, et al. Among authors: eisavand mr.
Cancer Cell Int. 2021 Apr 9;21(1):200. doi: 10.1186/s12935-021-01899-8.
Cancer Cell Int. 2021.
PMID: 33836774
Free PMC article.
Review.
Item in Clipboard
Triple-negative breast cancer: understanding Wnt signaling in drug resistance.
Merikhian P, Eisavand MR, Farahmand L.
Merikhian P, et al. Among authors: eisavand mr.
Cancer Cell Int. 2021 Aug 10;21(1):419. doi: 10.1186/s12935-021-02107-3.
Cancer Cell Int. 2021.
PMID: 34376211
Free PMC article.
Review.
Item in Clipboard
Anti-cancer therapeutic strategies based on HGF/MET, EpCAM, and tumor-stromal cross talk.
Barzaman K, Vafaei R, Samadi M, Kazemi MH, Hosseinzadeh A, Merikhian P, Moradi-Kalbolandi S, Eisavand MR, Dinvari H, Farahmand L.
Barzaman K, et al. Among authors: eisavand mr.
Cancer Cell Int. 2022 Aug 19;22(1):259. doi: 10.1186/s12935-022-02658-z.
Cancer Cell Int. 2022.
PMID: 35986321
Free PMC article.
Review.
Item in Clipboard
MUC1 is a potential target to overcome trastuzumab resistance in breast cancer therapy.
Hosseinzadeh A, Merikhian P, Naseri N, Eisavand MR, Farahmand L.
Hosseinzadeh A, et al. Among authors: eisavand mr.
Cancer Cell Int. 2022 Mar 5;22(1):110. doi: 10.1186/s12935-022-02523-z.
Cancer Cell Int. 2022.
PMID: 35248049
Free PMC article.
Review.
Item in Clipboard
Cite
Cite